GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Other Current Payables

Zelira Therapeutics (ASX:ZLD) Other Current Payables : A$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Other Current Payables?

Zelira Therapeutics's Other Current Payables for the quarter that ended in Jun. 2024 was A$0.00 Mil.


Zelira Therapeutics Other Current Payables Historical Data

The historical data trend for Zelira Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Other Current Payables Chart

Zelira Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zelira Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zelira Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Zelira Therapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Zelira Therapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Zelira Therapeutics Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics Headlines

No Headlines